Investor Relations

Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company.

  1. Aug 28, 2024

    2024 Interim Results Online Conference

  2. Mar 28, 2024

    2023 Annual Results Online Conference

  3. Dec 15, 2023

    HBM 9033 Out-license to Pfizer

  4. Aug 29, 2023

    2023 Interim Results Online Conference

  5. Mar 29, 2023

    2022 Annual Results Online Conference